Harriet de Wit
Director/Board Member at PHARMALA BIOTECH HOLDINGS INC.
Net worth: 15 800 $ as of 2024-04-29
Profile
Harriet de Wit is currently a Director at Pharmala Biotech Holdings, Inc. and Pharmala Biotech, Inc. She is also a Professor at The University of Chicago.
She received her doctorate degree from Concordia University in 1981 and her undergraduate degree from the University of Calgary.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-26 | 100,000 ( 0.12% ) | 15 800 $ | 2024-04-29 |
Harriet de Wit active positions
| Companies | Position | Start |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director/Board Member | 2021-03-20 |
| The University of Chicago | Corporate Officer/Principal | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Director/Board Member | - |
Training of Harriet de Wit
| Concordia University | Doctorate Degree |
| University of Calgary | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Harriet de Wit
